# Eton Pharmaceuticals, Inc. (ETON)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ETON/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 61.86M | $ 13.13M | $ 14.59M | $ 28.99M | $ 46.59M |
| 2025 | $ 81.86M | $ -4.71M | $ 10.43M | $ 9.25M | $ 26.15M |
| 2024 | $ 41.00M | $ -4.02M | $ -972.2K | $ 29.99M | $ 24.43M |
| 2023 | $ 34.21M | $ -1.01M | $ 6.53M | $ 5.46M | $ 15.48M |
| 2022 | $ 23.74M | $ -10.08M | $ 2.27M | $ 6.52M | $ 13.08M |
| 2021 | $ 25.95M | $ -2.32M | $ -9.49M | $ 6.70M | $ 17.63M |
| 2020 | $ 49.7K | $ -35.63M | $ -28.53M | $ 7.14M | $ 15.66M |
| 2019 | $ 1.24M | $ -23.65M | $ -24.68M | $ 4.56M | $ 10.55M |
| 2018 | $ 0 | $ -16.83M | $ -11.07M | $ 0 | $ 26.30M |
| 2017 | $ 0 | $ -16.53M | $ -6.67M | $ 0 | $ 12.13M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.62 |
| Liabilities / Eq | 1.49 |
| Current Ratio | 1.52 |

## Other views

- [Metrics](https://sponda.capital/en/ETON.md)
- [Charts](https://sponda.capital/en/ETON/charts.md)
- [Compare](https://sponda.capital/en/ETON/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.